查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
歐洲微陣列分析市場：按產品、類型、應用、最終用戶、國家 - 分析和預測（2023-2033）
市場調查報告書
商品編碼
1594216

歐洲微陣列分析市場：按產品、類型、應用、最終用戶、國家 - 分析和預測（2023-2033）

Europe Microarray Analysis Market: Focus on Product, Type, Application, End User, and Country Level Analysis - Analysis and Forecast, 2023-2033
出版日期: | 出版商: BIS Research | 英文 79 Pages | 商品交期: 1-5個工作天內

價格

2023年歐洲微陣列分析市場規模為16.902億美元。預計2033年市場規模將達32.36億美元，2023-2033年預測期間複合年成長率為6.71%。歐洲微陣列分析市場的成長是由基因組學計劃數量的增加、藥物篩檢中微陣列技術的使用增加以及癌症篩檢中的日益採用所推動的。該市場涵蓋各種消耗品、設備、軟體和服務，支持該全部區域基因組學和個人化醫療的進步。

主要市場統計數據
預測期 2023-2033
2023年評估 16.902 億美元
2033 年預測 32.36億美元
複合年成長率 6.71%

由於生物技術、個人化醫療和基因組學研究的市場開拓，歐洲微陣列分析市場正在顯著成長。藥物發現、疾病診斷和生物標記鑑定都在很大程度上依賴微陣列技術，該技術能夠分析基因表現、基因突變和其他分子資料。微陣列分析的使用正在許多行業中迅速擴展，包括醫療保健、製藥和農業，其中歐洲處於基因組研究和創新的前沿。

該行業正在受到越來越多的基因組學計劃和計劃的推動，這些計畫和計劃尋求高通量、負擔得起的基因分析工具。此外，由於微陣列在藥物開發和癌症篩檢，該市場正在開拓，這使得早期檢測、個人化治療策略和治療標靶的識別成為可能。

耗材、設備、軟體和服務是關鍵市場類別，對於臨床和研究環境中微陣列分析的成功至關重要。歐洲市場的領先公司正在專注於開發提高擴充性、準確性和靈敏度的技術。隨著分子診斷和精準醫療需求的不斷成長，歐洲微陣列分析市場預計將進一步成長，推動生物技術和醫療保健的發展。

該報告考察了歐洲微陣列分析市場，並提供了市場概況，包括按產品、類型、應用、最終用戶、國家和參與市場的公司概況分類的趨勢。

目錄

執行摘要

第1章 市場

  • 趨勢：當前和未來的影響評估
  • 生態系概觀：微陣列分析市場
  • 研究發展回顧
  • 監管狀況
  • 全球重大事件的影響分析 - COVID-19
  • 價格分析
  • 市場動態概覽

第2章 區域

  • 區域概況
  • 促進因素和抑制因素
  • 歐洲

第3章市場－競爭基準化分析與公司概況

  • 未來展望
  • 競爭力評估
    • F. Hoffmann-La Roche Ltd.
    • Merck KGaA

第4章調查方法

Product Code: BHP2397SS

Introduction to Europe Microarray Analysis Market

The Europe microarray analysis market was valued at $1,690.2 million in 2023 and is expected to reach $3,236.0 million by 2033, growing at a CAGR of 6.71% during the forecast period 2023-2033. This growth in the Europe microarray analysis market is driven by the increasing number of genomics projects, the growing use of microarray technology in drug screening, and its expanding adoption in cancer screening. The market encompasses a wide range of consumables, instruments, software, and services, supporting advancements in genomics and personalized medicine across the region.

Market Introduction

KEY MARKET STATISTICS
Forecast Period2023 - 2033
2023 Evaluation$1,690.2 Million
2033 Forecast$3,236.0 Million
CAGR6.71%

The market for microarray analysis in Europe has grown significantly due to developments in biotechnology, personalized medicine, and genomics research. Drug discovery, disease diagnosis, and biomarker identification all heavily rely on microarray technology, which makes it possible to analyze gene expression, genetic variation, and other molecular data. The use of microarray analysis is spreading quickly across a number of industries, including healthcare, pharmaceuticals, and agriculture, as Europe remains at the forefront of genomic research and innovation.

The growing number of genomics projects and efforts, which call for high-throughput and reasonably priced genetic analysis tools, is driving the industry. Additionally, the market is expanding because to the increasing use of microarrays in drug development and cancer screening, which allow for early detection, individualized treatment strategies, and the identification of therapeutic targets.

Consumables, instruments, software, and services are important market categories that are essential to the success of microarray analysis in clinical and research settings. Leading firms in the European market are concentrating on developing technologies to increase scalability, precision, and sensitivity. With the growing need for molecular diagnostics and precision medicine, the European microarray analysis market is expected to grow further, propelling biotechnology and healthcare developments.

Market Segmentation:

Segmentation 1: by Product Type

  • Instruments
  • Consumables
  • Software and Services

Segmentation 2: by Type

  • DNA Microarray
  • Protein Microarray
  • Other Microarray

Segmentation 3: by Application

  • Clinical Diagnostics
  • Drug Discovery and Translational Research
  • Others

Segmentation 4: by End User

  • Pharmaceutical and Biotechnology Companies
  • Diagnostic Laboratories
  • Academic and Research Institutes
  • Others

Segmentation 5: by Country

  • France
  • Germany
  • Italy
  • Spain
  • U.K.
  • Rest-of-Europe

How can this report add value to an organization?

Workflow/Innovation Strategy: The Europe microarray analysis market (by product) has been segmented into detailed segments, including different types of consumables, such as arrays, kits and reagents, and accessories as well as instruments, and software and services.

Growth/Marketing Strategy: A strategic growth and marketing approach for the microarray analysis market would involve positioning the company as a leader in innovative solutions that address the evolving needs of researchers, clinicians, and pharmaceutical partners. This would entail leveraging technological advancements to develop cutting-edge products with enhanced sensitivity, specificity, and scalability, while also investing in comprehensive customer support, training programs, and collaborative partnerships to foster customer loyalty and drive market penetration.

Competitive Strategy: Key players in the Europe microarray analysis market have been focusing on innovation, differentiation, and strategic collaborations to gain a competitive edge. By investing in research and development, companies can develop novel detection methods, improve assay sensitivity, and expand application areas. Differentiation through the development of proprietary technologies, customizable solutions, and value-added services can help companies stand out in a crowded market. to strengthen market positions, acquire new technologies, and broaden product portfolios.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on thorough secondary research, which includes analyzing company coverage, product portfolio, market penetration, and insights gathered from primary experts.

Some prominent names established in this market are:

  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA

Table of Contents

Executive Summary

Scope and Definition

1 Markets

  • 1.1 Trends: Current and Future Impact Assessment
    • 1.1.1 Key Trends
      • 1.1.1.1 Technological Advancements in Microarray Analysis
      • 1.1.1.2 Developing Focus on Automation and Artificial Intelligence Integration in Microarray Analysis
  • 1.2 Ecosystem Overview: Microarray Analysis Market
    • 1.2.1 Value Addition Across the Process
  • 1.3 Research and Development Review
    • 1.3.1 Patent Filing Trend (by Country, Company)
  • 1.4 Regulatory Landscape
  • 1.5 Impact Analysis for Key Global Events - COVID-19
  • 1.6 Pricing Analysis
  • 1.7 Market Dynamics Overview
    • 1.7.1 Market Drivers
      • 1.7.1.1 Rising Numbers of Genomics Projects Fuelling the Growth of Microarray Analysis Market
      • 1.7.1.2 Use of Microarray Technology in Drug Discovery
      • 1.7.1.3 Increasing Adoption of Microarray Technology in Cancer Screening
    • 1.7.2 Market Restraints
      • 1.7.2.1 Competition from Alternative Technologies such as NGS
      • 1.7.2.2 Challenges in Complex Data Analysis due to Lack of Skilled Professionals
    • 1.7.3 Market Opportunities
      • 1.7.3.1 Novel Biomarker Discovery with the Use of Microarray Technology
      • 1.7.3.2 Utilization of Predictive Genomics for the Development of Personalized Medicines

2 Regions

  • 2.1 Regional Summary
  • 2.2 Drivers and Restraints
  • 2.3 Europe
    • 2.3.1 Regional Overview
    • 2.3.2 Driving Factors for Market Growth
    • 2.3.3 Factors Challenging the Market
    • 2.3.4 Germany
    • 2.3.5 U.K.
    • 2.3.6 France
    • 2.3.7 Italy
    • 2.3.8 Spain
    • 2.3.9 Rest-of-Europe

3 Markets - Competitive Benchmarking & Company Profiles

  • 3.1 Next Frontiers
  • 3.2 Competitive Assessment
    • 3.2.1 F. Hoffmann-La Roche Ltd.
      • 3.2.1.1 Overview
      • 3.2.1.2 Top Products/Product Portfolio
      • 3.2.1.3 Top Competitors
      • 3.2.1.4 Key Personnel
      • 3.2.1.5 Analyst View
    • 3.2.2 Merck KGaA
      • 3.2.2.1 Overview
      • 3.2.2.2 Top Products/Product Portfolio
      • 3.2.2.3 Top Competitors
      • 3.2.2.4 Key Personnel
      • 3.2.2.5 Analyst View

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation
  • 4.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Europe Microarray Analysis Market, $Million, 2023, 2026, and 2033
  • Figure 2: Microarray Analysis Market (by Region), $Million, 2022, 2026, and 2033
  • Figure 3: Europe Microarray Analysis Market (by Application), $Million, 2022, 2026, and 2033
  • Figure 4: Europe Microarray Analysis Market (by Type), $Million, 2022, 2026, and 2033
  • Figure 5: Europe Microarray Analysis Market (by Product), $Million, 2022, 2026, and 2033
  • Figure 6: Europe Microarray Analysis Market (by End User), $Million, 2022, 2026, and 2033
  • Figure 7: Key Industrial Developments in Microarray Analysis Market, 2023
  • Figure 8: Opportunities in Genetic Research through AI and Automation
  • Figure 9: Ecosystem Overview of Microarray Analysis Market and Operational Challenges
  • Figure 10: Microarray Analysis Market, Patent Analysis (by Country), January 2020-December 2023
  • Figure 11: Microarray Analysis Market, Patent Analysis (by Year), January 2020-December 2023
  • Figure 12: Examples of the Key Initiative Related to Genomics
  • Figure 13: Applications of Microarray Analysis Technology in Drug Discovery
  • Figure 14: Microarray vs. RNA Sequencing, NGS, and PCR
  • Figure 15: Pitfalls in Data Analysis due to Lack of Skilled Professionals
  • Figure 16: Key Initiatives Focused on Pharmacogenomics to Improve the Landscape of Precision Medicine
  • Figure 17: Precision Medicine vs. Other Medicine
  • Figure 18: Germany Microarray Analysis Market, $Million, 2022-2033
  • Figure 19: U.K. Microarray Analysis Market, $Million, 2022-2033
  • Figure 20: France Microarray Analysis Market, $Million, 2022-2033
  • Figure 21: Italy Microarray Analysis Market, $Million, 2022-2033
  • Figure 22: Spain Microarray Analysis Market, $Million, 2022-2033
  • Figure 23: Strategic Initiatives, 2021-2024
  • Figure 24: Share of Strategic Initiatives, 2021-2024
  • Figure 25: Data Triangulation
  • Figure 26: Top-Down and Bottom-Up Approach
  • Figure 27: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Microarray Analysis Market, Opportunities
  • Table 3: Key Companies and Technological Advancements, 2022-2023
  • Table 4: Pricing Analysis of Microarray Analysis Products (Instruments and Consumables)
  • Table 5: Impact Analysis of Market Navigating Factors, 2022-2033
  • Table 6: Examples of Arrays Used in Cancer Screening
  • Table 7: Microarray Analysis Market (by Region), $Million, 2022-2033
  • Table 8: Europe Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 9: Europe Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 10: Europe Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 11: Europe Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 12: Germany Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 13: Germany Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 14: Germany Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 15: Germany Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 16: U.K. Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 17: U.K. Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 18: U.K. Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 19: U.K. Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 20: France Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 21: France Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 22: France Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 23: France Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 24: Italy Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 25: Italy Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 26: Italy Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 27: Italy Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 28: Spain Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 29: Spain Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 30: Spain Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 31: Spain Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 32: Rest-of-Europe Microarray Analysis Market, $Million, 2022-2033
  • Table 33: Rest-of-Europe Microarray Analysis Market (by Product), $Million, 2022-2033
  • Table 34: Rest-of-Europe Microarray Analysis Market (by Type), $Million, 2022-2033
  • Table 35: Rest-of-Europe Microarray Analysis Market (by Application), $Million, 2022-2033
  • Table 36: Rest-of-Europe Microarray Analysis Market (by End User), $Million, 2022-2033
  • Table 37: Company Market Share, 2022